"We are pleased to have Retasure available for Charlotte-area diabetics", stated Scott Sanner, Senior Vice President, North American Operations of Digital Healthcare. "Carolina Diabetes and Endocrine Clinic is a leader in providing excellent services for diabetic patients. Now, they can also provide diabetic retinopathy risk assessments using the Retasure solution."
Dr. Alfred Okeke directs the Diabetes and Endocrine Clinic. He is a fellow of the American College of Endocrinologists and is board certified in Internal Medicine, as well as Endocrinology, Diabetes and Metabolism. "Retasure is one more tool that we have in our effort to better diagnose and treat the effects of this serious disease."
The FDA-approved and HEDIS compliant Retasure solution provides a simple, affordable, and non-invasive solution that allows physicians to capture their patients' retinal images during a three to five minute procedure. Images are transmitted over a secure, HIPAA compliant network to an accredited reading centre. A state-licensed and board-certified ophthalmologist reviews the images and results are returned to the original physician within 72 hours.
There are an estimated 20 million diabetic patients in the United States, but only about half have any retinal assessments, despite a high risk of diabetic retinopathy. The National Eye Institute indicates diabetic retinopathy is the leading cause of blindness among working age American adults. More than a million patients around the world have received a retinal risk assessment using Digital Healthcare software.
Digital Healthcare is a global expert in retinal risk assessment. The company is a provider of care management programmes for diabetic retinopathy. Its award-winning MS-HUG technology is used by leading hospitals and research centres including University Hospitals Case Medical Center at Case Western Reserve University, The Wilmer Eye Institute at The Johns Hopkins University and the United States Military.
Digital Healthcare's Retasure solution offers several advantages for primary care and endocrinologist physicians and their patients. It can be operated by non-clinicians; it is non-invasive and requires no dilation; it obtains exceptionally high-quality digital images of the retina using a simple-to-operate fundus camera; it returns results quickly to the ordering physicians; and it encourages patient compliance for retinal evaluation and comprehensive eye examinations.